Back to results
US 8,299,128 B2Granted
Compositions comprising polymeric micelles for drug delivery
AssigneeIntezyne Technologies, Inc.
InventorsKevin N. Sill, Habib Skaff, Kurt Breitenkamp, Rebecca Breitenkamp
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and micelles comprising the same.
Claims23
A composition comprising a drug-loaded micelle and a pharmaceutically acceptable carrier, adjuvant, or vehicle, wherein the micelle comprises a multiblock copolymer, wherein said micelle has a drug-loaded inner core, a non-crosslinked outer core, and a hydrophilic shell, wherein the multiblock copolymer is of formula I:
- wherein:
- n is 10-2500;
- m is 1 to 1000;
- m′ is 1 to 1000;
- Rx is a natural or unnatural amino acid side-chain group that is capable of crosslinking;
- Ry is a hydrophobic or ionic, natural or unnatural amino acid side-chain group;
- R1 is —Z(CH2CH2Y)p(CH2)tR3, wherein:
- Z is —O—, —S—, —C≡C—, or —CH2—;
- each Y is independently —O— or —S—;
- p is 0-10;
- t is 0-10;
- and
- R3 is —N3, —CN, a mono-protected amine, a di-protected amine, a protected aldehyde, a protected hydroxyl, a protected carboxylic acid, a protected thiol, a 9-30 membered crown ether, or an optionally substituted group selected from aliphatic, a 5-8 membered saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, an 8-10 membered saturated, partially unsaturated, or aryl bicyclic ring having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a detectable moiety;
- Q is a valence bond or a bivalent, saturated or unsaturated, straight or branched C1-12 alkylene chain, wherein 0-6 methylene units of Q are independently replaced by -Cy-, —O—, —NH—, —S—, —OC(O)—, —C(O)O—, —C(O)—, —SO—, —SO2—, —NHSO2—, —SO2NH—, —NHC(O)—, —C(O)NH—, —OC(O)NH—, or —NHC(O)O—, wherein:
- -Cy- is an optionally substituted 5-8 membered bivalent, saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an optionally substituted 8-10 membered bivalent saturated, partially unsaturated, or aryl bicyclic ring having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur;
- R2a is a mono-protected amine, a di-protected amine, —N(R4)2, —NR4C(O)R4, —NR4C(O)N(R4)2, —NR4C(O)OR4, or —NR4SO2R4;
- and
- each R4 is independently an optionally substituted group selected from hydrogen, aliphatic, a 5-8 membered saturated, partially unsaturated, or aryl ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, an 8-10 membered saturated, partially unsaturated, or aryl bicyclic ring having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a detectable moiety, or:
- two R4 on the same nitrogen atom are taken together with said nitrogen atom to form an optionally substituted 4-7 membered saturated, partially unsaturated, or aryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur.
16 more elements
Dependencies are inferred from the claim text.